Evidence map›Paper›PMID 40724034›Full record

ArticleAntibiotics (Basel, Switzerland)2025

Preliminary Evaluation of the Synergistic Antibacterial Effects of Selected Commercial Essential Oil Compounds Against Methicillin-Resistant

Kacper Hartman, Maja Świerczyńska, Amelia Wieczorek, Piotr Baszuk, Iwona Wojciechowska-Koszko, Katarzyna Garbacz, Monika Sienkiewicz, Paweł Kwiatkowski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kacper HartmanDepartment of Diagnostic Immunology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.ORCID 0009-0001-2739-3612
Maja ŚwierczyńskaDepartment of Diagnostic Immunology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.
Amelia WieczorekDepartment of Diagnostic Immunology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.ORCID 0009-0002-9190-2423
Piotr BaszukDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.ORCID 0000-0002-0676-2597
Iwona Wojciechowska-KoszkoDepartment of Diagnostic Immunology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.ORCID 0000-0003-4887-4113
Katarzyna GarbaczDepartment of Oral Microbiology, Medical Faculty, Medical University of Gdansk, 80-204 Gdansk, Poland.ORCID 0000-0001-9359-7966
Monika SienkiewiczDepartment of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Lodz, 90-151 Lodz, Poland.ORCID 0000-0002-9823-4176
Paweł KwiatkowskiDepartment of Diagnostic Immunology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.ORCID 0000-0003-0016-0541

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibacterial activitycheckerboardessential oil compoundsMRSAsynergism

Identifiers

PMID40724034
PMCPMC12291983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.